๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 11 Beijing 3 Hanzhou 2 Nanjing 2 Hangzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou11 Beijing3 Hanzhou2 Nanjing2 Hangzhou1
All 8 locations
Target enrolment
to

Trials with a site in Guangzhou

11 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC
NCT07267806Hepato Cellular Carcinoma (HCC), Chemotherapy Effect
Linhui Peng
Phase 3
326
Guangzhou
2025-10-31
Recruiting
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
NCT06510010Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
198
Guangzhou
2024-12-31
Not yet open
Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma
NCT06567600Intrahepatic Cholangiocarcinoma, Chemotherapy Effect, Immunotherapy
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2
43
Guangzhou
2024-09-01
Recruiting
Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC
NCT06041477Hepatocellular Carcinoma, Chemotherapy Effect, Chemotherapeutic Toxicity
Sun Yat-sen University
Phase 3
540
Guangzhou
2023-10-31
Recruiting
Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
NCT06043999Chemotherapy Effect, Rectal Cancer
Sun Yat-sen University
Not applicable
392
Guangzhou
2023-09-01
Recruiting
Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC
NCT06172205BCLC Stage C Hepatocellular Carcinoma, Chemotherapy Effect
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
262
Guangzhou
2023-07-01
Recruiting
Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients
NCT05797467Colorectal Cancer, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
366
Guangzhou
2023-04-01
Recruiting
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
NCT05815082Colorectal Cancer, Liver Metastases, Circulating Tumor Cell, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
490
Guangzhou
2023-02-20
Recruiting
S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma
NCT04989985Locally Advanced Gastroesophageal Junction Adenocarcinoma, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
302
Guangzhou
2021-09-01
Recruiting
Topotecan and Melphalan for Retinoblastoma
NCT04799002Retinoblastoma, Chemotherapy Effect
Sun Yat-sen University
Phase 3
50
Guangzhou
2021-03-11
Recruiting
Predicting Gastric Cancer Response to Chemo With Multimodal AI Model
NCT06451393Gastric Cancer, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
500
Guangzhou
2013-02-01
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Guangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Guangzhou?

10 of the 11 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Guangzhou), 11 studies
PhaseStudiesRecruitingShare
Phase 36654.5%
Phase 23227.3%
Not applicable119.1%
Observational119.1%

Most active sponsors

Lead sponsors with the most studies (Guangzhou)
Lead sponsorStudiesRecruiting
Sixth Affiliated Hospital, Sun Yat-sen University55
Sun Yat-sen University33
Linhui Peng11
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University11
Third Affiliated Hospital, Sun Yat-Sen University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.